InvestorsObserver
×
News Home

Premarket Mover: Protalix Biotherapeutics Inc (PLX) Down 4.39%

Monday, September 19, 2022 06:59 AM | InvestorsObserver Analysts

Mentioned in this article

Premarket Mover: Protalix Biotherapeutics Inc (PLX) Down 4.39%

Protalix Biotherapeutics Inc (PLX) has fallen Monday morning, with the stock falling -4.39% in pre-market trading to 1.09. PLX's short-term technical score of 95 indicates that the stock has traded more bullishly over the last month than 95% of stocks on the market. In the Biotechnology industry, which ranks 118 out of 146 industries, Protalix Biotherapeutics Inc ranks higher than 96% of stocks. Protalix Biotherapeutics Inc has fallen 5.00% over the past month, closing at $1.13 on August 22. During this period of time, the stock fell as low as $1.03 and as high as $1.20. The company has an average price target of $11.00.

Overall Score - 60
PLX has an Overall Score of 60. Find out what this means to you and get the rest of the rankings on PLX!
Protalix Biotherapeutics Inc has a Long-Term Technical rank of 84. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 16% of the market scoring higher. In the Biotechnology industry which is number 47 by this metric, PLX ranks better than 47% of stocks.

Important Dates for Investors in PLX:

-Protalix Biotherapeutics Inc is set to release earnings on 11/13/2022. Over the last 12 months, the company has reported EPS of $-0.39. -We do not have a set dividend date for Protalix Biotherapeutics Inc at this time. Click Here To Get The Full Report on Protalix Biotherapeutics Inc (PLX)

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App